Endologix Inc. provided revenue guidance for the fourth quarter of 2012 and revised revenue guidance for the full year ended December 31, 2012. The company anticipates fourth quarter 2012 global revenue of approximately $29.2 million, representing approximately 25% year over year growth. The company anticipates U.S. revenue to be approximately $23.3 million in the fourth quarter of 2012, representing approximately 20% growth compared to $19.4 million for the same quarter in 2011. International revenue is anticipated to be approximately $5.9 million in the fourth quarter of 2012, representing approximately 48% growth compared to $4.0 million for the same quarter in 2011.

For the full year 2012, the company expects global revenue of approximately $105.9 million, representing approximately 27% year over year growth. The preliminary results compare to previously issued guidance of $104 million to $106 million in global revenues for the full year 2012.